Kehrmann Jan, Dostmohammadi Alireza, Stumpf Anna-Lena, Best Lara, Consten Leah, Sievert Hannah, Maischack Felix, Sammet Stefanie, Albayrak-Rena Sarah, Doerr Ann-Kathrin, Bohlen Katharina, von Velsen Otgonzul, Kraiselburd Ivana, Karsten Christina B, Farahpour Farnoush, Meyer Folker, Esser Stefan, Buer Jan
Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Bioinformatics and Computational Biophysics, Faculty of Biology and Centre for Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany.
Front Cell Infect Microbiol. 2025 May 8;15:1568352. doi: 10.3389/fcimb.2025.1568352. eCollection 2025.
Specific antiretroviral therapy (ART) regimens are associated with weight gain in people living with HIV (PLWH). Gut microbiota is involved in weight gain in humans and animals. Human gut microbiota can be classified into enterotypes with distinct microbial and functional profiles.
In a cohort of 118 PLWH, we analyzed the gut microbiome in relation to weight gain and ART regimen using gene sequencing, taking enterotype classification into account.
The enterotype was strongly associated with sexual orientation. Of the 67 individuals forming a -dominated enterotype cluster in principal coordinates analysis, 93% were men who had sex with men (MSM), while 31% of individuals in the -dominated enterotype cluster were MSM and 69% were non-MSM. Forty-nine genera differed significantly between the MSM and non-MSM individuals. When stratified by dominant genus, only six taxa were associated with weight gain. Of these, five were restricted to -dominated individuals. Among them, the class Actinobacteria and genus differed between individuals gaining more than 5% weight and less than 5% weight 1 year after ART switch. Additionally, three taxa were significantly different between 15% of individuals with the highest weight gain (≥6.3%) and the highest weight loss (≤3.19%) 1 year after ART switch, including the phyla Firmicutes, Verrucomicrobia, and Synergistetes. Distinct functional properties in , but not -dominated enterotype individuals, linked to weight gain were observed, particularly for glycan and lipid metabolism. Additionally, ART regimen-associated differences were observed for the phylum Actinobacteria, although this was limited to dominated enterotype individuals.
Differences in the composition and functional characteristics of the gut microbiome associated with weight gain and ART regimens were enterotype-specific and relatively small compared with differences linked to sexual orientation. Due to the substantial differences in gut microbiome structure among many MSM, categorization into enterotypes is useful for identifying differences in microbiome composition associated with variables such as weight gain or ART, which may be limited to a single enterotype. This may further advance the identification of microbes that contribute to weight gain or alter the gut microbiome composition in the context of the enterotype.
特定的抗逆转录病毒疗法(ART)方案与人类免疫缺陷病毒感染者(PLWH)体重增加有关。肠道微生物群与人类和动物的体重增加有关。人类肠道微生物群可分为具有不同微生物和功能特征的肠型。
在一个由118名PLWH组成的队列中,我们使用基因测序分析了肠道微生物组与体重增加和ART方案的关系,并考虑了肠型分类。
肠型与性取向密切相关。在主坐标分析中形成以-为主的肠型簇的67名个体中,93%是男男性行为者(MSM),而在以-为主的肠型簇中,31%的个体是MSM,69%是非MSM。MSM个体和非MSM个体之间有49个属存在显著差异。按优势属分层时,只有6个分类单元与体重增加有关。其中,5个仅限于以-为主的个体。其中,放线菌纲和属在ART转换后1年体重增加超过5%和体重增加低于5%的个体之间存在差异。此外,在ART转换后1年体重增加最高(≥6.3%)和体重减轻最高(≤3.19%)的15%个体之间,有3个分类单元存在显著差异,包括厚壁菌门、疣微菌门和协同菌门。在以-为主但不以-为主的肠型个体中,观察到与体重增加相关的不同功能特性,特别是在聚糖和脂质代谢方面。此外,虽然仅限于以-为主的肠型个体,但在放线菌门中观察到了与ART方案相关的差异。
与体重增加和ART方案相关的肠道微生物组组成和功能特征的差异是肠型特异性的,与与性取向相关的差异相比相对较小。由于许多MSM的肠道微生物组结构存在很大差异,将其分类为肠型有助于识别与体重增加或ART等变量相关的微生物组组成差异,这些差异可能仅限于单一肠型。这可能会进一步推动对导致体重增加或在肠型背景下改变肠道微生物组组成的微生物的识别。